Actively Recruiting
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Led by Guangdong Hengrui Pharmaceutical Co., Ltd · Updated on 2026-04-08
200
Participants Needed
2
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial was designed to evaluate the efficacy and safety of SHR-1819 in adult patients with moderate-to-severe atopic dermatitis.
CONDITIONS
Official Title
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years, male or female
- Signed informed consent and able to communicate smoothly with the researcher
- Applying topical emollients twice daily at a stable dose for at least 7 days before first dose and continuing during the study
- Have atopic dermatitis at screening and a history of atopic dermatitis for at least 1 year before screening
- Have moderate to severe atopic dermatitis at screening and on the day of first dose
You will not qualify if you...
- Have other active skin diseases or skin complications affecting atopic dermatitis evaluation
- History of spring keratoconjunctivitis and/or atopic keratoconjunctivitis within 6 months before screening
- Have or have had malignancy
- Have serious concomitant diseases or conditions deemed unsuitable by the investigator
- Hypersensitivity to SHR-1819 or any ingredient in the study drug
- Females who are pregnant or lactating
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China, 510091
Actively Recruiting
2
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
R
Ran Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here